Jared B. Fox, PhD1, Frederic E. Shaw, MD, JD2 (Author affiliations at end of text)
    
Each year in the United States, an estimated 100,000 deaths could
 be prevented if persons received recommended clinical preventive care (1). 
The Affordable Care Act has reduced cost as a barrier to care by 
expanding access to insurance and requiring many health plans to cover 
certain recommended preventive services without copayments or 
deductibles. 
To establish a baseline for the receipt of these services 
and to begin monitoring the effects of the law, CDC analyzed responses 
from persons aged ≥18 years in the National Health Interview Survey 
(NHIS) for the years 2011 and 2012 combined. 
This report summarizes the 
findings for six services covered by the Affordable Care Act. 
Among the 
six services examined, three were received by less than half of the 
persons for whom they were recommended (testing for human 
immunodeficiency virus [HIV] and vaccination for influenza and zoster 
[shingles]). 
Having health insurance or a higher income was associated 
with higher rates of receiving these preventive services, affirming 
findings of previous studies (2 
).  
Securing health insurance coverage might be an important way to 
increase receipt of clinical preventive services, but insurance coverage
 is not all that is needed to ensure that everyone is offered and uses 
clinical services proven to prevent disease. 
Greater awareness of 
Affordable Care Act provisions among public health professionals, 
partners, health care providers, and patients might help increase the 
receipt of recommended services (3).
    
The analysis focused on responses to questions about the receipt 
of six clinical preventive services recommended by the U.S. Preventive 
Services Task Force (USPSTF) or the Advisory Committee for Immunization 
Practices (ACIP). 
The six preventive services are among dozens of 
services for adults covered without copayments or deductibles under 
certain health plans according to the Affordable Care Act,*
 and were selected for this analysis because the recommendations closely
 fit NHIS survey questions. 
The six were as follows: 
HIV testing, 
smoking cessation discussion, 
influenza vaccination, 
pneumococcal 
vaccination, 
tetanus vaccination, and 
zoster (shingles) vaccination. 
However, the recommendations and NHIS questions are not a perfect match. 
For example, cessation intervention is recommended for all forms of 
tobacco use, but respondents were only asked about receiving smoking 
cessation interventions. 
The fit between the NHIS questions and the 
recommendations varied among the six preventive services (Table 1).  
    
NHIS is administered by in-person interviews to a nationally 
representative sample of the noninstitutionalized, U.S. civilian 
population. 
For this analysis, NHIS data from the sample adult core 
questionnaire in 2011 and 2012 were combined to increase sample sizes 
and improve reliability of estimates. 
In each household identified, one 
adult (aged ≥18 years) from each family was randomly selected to 
complete the questionnaire.†
 NHIS 2011 and 2012 adult core samples included 33,014 and 34,525 
respondents, respectively, and the overall response rates were 66.3% and
 61.2%. 
    
Participants were asked whether they had health insurance at the 
time of the interview. 
They were considered uninsured if they reported 
currently not having private health insurance, Medicare, Medicaid, 
Children's Health Insurance Program, a state-sponsored or other 
government-sponsored health plan, or a military plan. 
Respondents also 
were defined as uninsured if they had only a private plan that paid for 
one type of service (e.g., injury or dental care) or had only Indian 
Health Service coverage.§ 
Multiple imputations were performed on family income to account for missing responses to income questions.¶ 
NHIS data were adjusted for nonresponse and weighted to provide 
national estimates of insurance status and receipt of preventive care; 
95% confidence intervals were calculated, taking into account the 
survey's multistage probability sample design. 
Generalized linear 
modeling and the t-test were used to calculate prevalence ratios and 
statistical significances of differences in preventive services receipt 
between 
1) persons who were insured and those who were uninsured, 
2) 
those with current family incomes >200% of the federal poverty level 
(FPL) ($46,100 for a family of four in 2012**)
 and those with incomes ≤200% of the FPL, and 
3) those with any private 
health insurance and those with only public coverage. 
    
For the six services examined, prevalence of receipt of service 
was as follows: 
zoster vaccination, 17.9%; 
influenza vaccination, 39.4%; 
HIV testing, 41.7%; 
smoking cessation discussion, 52.0%; 
pneumococcal 
vaccination, 61.4%; and 
tetanus vaccination, 62.0% (Table 2).  
A higher percentage of adults with health insurance received five of 
six recommended clinical preventive services (all but HIV testing) 
compared with those who were uninsured (Table 2).  
Among those five services, the service receipt prevalence ratio for 
those with insurance compared with those without insurance ranged from 
1.2 for tetanus vaccination to 3.4 for pneumococcal vaccination (Table 2).  
However, service receipt for persons with health insurance was <50% 
for three of six recommended clinical preventive services. 
    
Persons with family incomes >200% of the FPL received five of 
six recommended clinical preventive services at a statistically 
significant higher prevalence compared with those with incomes below 
that threshold (Table 3). 
Among those five services, the service receipt prevalence ratio for 
those with family incomes >200% of the FPL compared with those with 
incomes ≤200% of the FPL ranged from 1.1 for pneumococcal vaccination to
 1.9 for zoster vaccination (Table 3). 
    
Persons with private health insurance received three of six 
recommended clinical preventive services at a higher prevalence, and 
three of six at a lower prevalence, compared with those with only public
 insurance (Table 4).  
    
Discussion
 
    
The findings in this report indicate that during 2011–2012, large
 portions of the adult population were not receiving recommended 
preventive care, those with insurance were more likely to receive 
recommended preventive services than those without coverage, and those 
with higher income were more likely to receive recommended care. 
This 
supports previously published studies, including one that found 
prevalence ratios in the range of 1–3 for those with insurance receiving
 recommended preventive services compared with those without coverage (2 
).  
However, even among persons with insurance and higher income, in this 
analysis, receipt of recommended preventive services was suboptimal. 
    
This report could serve as a baseline for tracking the effects of
 the Affordable Care Act on the receipt of six preventive services. 
Although the law began to require certain plans to cover clinical 
preventive services in September 2010, the data from 2011–2012 provide a
 feasible baseline for measuring the law's effects because 
1) a high 
number of persons remained uninsured during 2011–2012, 
2) there was 
little awareness of the preventive care provisions of the new law, and 
3) many plans in existence before enactment of the Affordable Care Act 
were not subject to the preventive services provisions (4–6). 
    
The findings in this report are subject to at least four 
limitations. 
First, this was a cross-sectional study, and associations 
between receipt of a service and other factors do not imply a causal 
relationship. 
Second, insurance coverage and income level are just two 
of many factors that might be associated with service receipt rates. 
This analysis does not include possible confounders such as education, 
health status, or other factors. 
Third, receipt of preventive services 
was self-reported and might be subject to recall bias. 
Finally, 
inferences from these results are limited by differences in time between
 when the questions were asked and when the services were received. 
For 
example, NHIS identifies whether the respondent is insured at the time 
of interview; however, depending on the service, NHIS asks whether the 
respondent received preventive care in the last 12 months, last 10 
years, or ever during their lifetime. 
Currently uninsured respondents 
might have received preventive care during a time when they had 
insurance, or vice versa. 
In addition, NHIS is limited to 
noninstitutionalized civilians, excluding certain populations (e.g., the
 institutionalized and the military) that might be especially likely to 
receive recommended preventive services. 
    
All new private health plans, alternative benefit plans for the 
newly Medicaid eligible, and Medicare now provide coverage without 
copayments or deductibles for recommended clinical preventive services. 
By expanding access to insurance and requiring many plans to cover 
recommended clinical preventive services, the Affordable Care Act is 
expected to reduce barriers to receipt of recommended preventive care. 
The number of uninsured persons aged <65 years is expected to drop 
from 55 million in 2013 to 30 million in 2017 (7). 
    
Lack of insurance, however, is not the only barrier to receiving 
services; a number of other factors likely will continue to inhibit 
receipt of preventive care. 
First, many persons are currently insured 
under "grandfathered" health plans not required to provide coverage 
without copayments or deductibles for all recommended preventive 
services (8). 
Second, other barriers, such as transportation 
costs and lack of a regular physician, might inhibit receipt of 
recommended preventive care. 
Finally, even after the Affordable Care Act
 is implemented fully, millions of persons are expected to remain 
uninsured (7). 
To date, about half of the 50 states have not yet 
implemented the law's expansion of Medicaid, leaving an estimated 40% of
 their adult residents who have been uninsured in the last 2 years 
without access to affordable care (9). 
Studies have indicated 
that 60%–74% of children who are eligible for Medicaid are uninsured, in
 part as a result of failure to renew enrollment in Medicaid (10). 
Efforts to increase enrollment and coverage retention could help these 
populations maintain continuous coverage, thereby increasing receipt of 
preventive services and reducing avoidable complications from illness, 
long-term health care costs, and premature deaths (10).
Office of Health System Collaboration, Office of the Associate Director for Policy, CDC; 2Center for Surveillance, Epidemiology, and Laboratory Services, CDC 
 
(Corresponding author: 
                
    
References
    
-  National Commission on Prevention Priorities. Preventive 
care: a national profile on use, disparities, and health benefits. 
Washington, DC: Partnership for Prevention, National Commission on 
Prevention Priorities; 2007. Available at http://www.prevent.org/data/files/initiatives/ncpppreventivecarereport.pdf 

. 
-  CDC. Use of selected clinical preventive services among adults—United States, 2007–2010. MMWR 2012;61(Suppl) 
.  
-  Frieden TR. Six components necessary for effective public health program implementation. Am J Public Health 2014;104:17–22.
 
-  Kaiser Family Foundation; Health Research and Educational 
Trust. Employer health benefits: 2011 annual survey. Menlo Park, CA: 
Kaiser Family Foundation; Chicago, IL: Health Research and Educational 
Trust; 2011. Available at http://kaiserfamilyfoundation.files.wordpress.com/2013/04/8225.pdf 

. 
-  Kaiser Family Foundation; Health Research and Educational 
Trust. Employer health benefits: 2012 annual survey. Menlo Park, CA: 
Kaiser Family Foundation; Chicago, IL: Health Research and Educational 
Trust; 2012. Available at http://kff.org/report-section/ehbs-2012-section-13
.  
-  Reed ME, Graetz I, Fung V, Newhouse JP, Hsu J. In 
consumer-directed health plans, a majority of patients were unaware of 
free or low-cost preventive care. Health Aff (Millwood) 2012;31:2641–8.
 
-  Congressional Budget Office. Insurance coverage provisions of 
the Affordable Care Act—CBO's February 2014 baseline. Washington, DC: 
Congressional Budget Office; 2014. Available at http://www.cbo.gov/sites/default/files/cbofiles/attachments/43900-2014-02-ACAtables.pdf 

. 
-  Kaiser Family Foundation; Health Research and Educational 
Trust. Employer health benefits: 2013 annual survey. Menlo Park, CA: 
Kaiser Family Foundation; Chicago, IL: Health Research and Educational 
Trust; 2013. Available at http://kaiserfamilyfoundation.files.wordpress.com/2013/08/8465-employer-health-benefits-20131.pdf 

. 
-  Rasmussen PW, Collins SR, Doty MM, Garber T. In states' hands: 
how the decision to expand Medicaid will affect the most financially 
vulnerable Americans. Issue Brief (Commonw Fund) 2013;23:1–8.  
 
-  Sommers BD. Why millions of children eligible for Medicaid and 
SCHIP are uninsured: poor retention versus poor take-up. Health Aff 
(Millwood) 2007;26:w560–7.
 
   
            
   
             
    
What is already known on this topic?
    
Rates of receipt of some clinical preventive 
services by adults are low, but higher for persons with insurance 
coverage or higher incomes. 
The Affordable Care Act's expansions of 
health insurance access and coverage requirements for clinical 
preventive services were developed to increase access to health services
 to improve the health of the population.
    
What is added by this report?
    
Analysis of combined adult responses to the 
National Health Interview Survey in 2011 and 2012 indicated that persons
 with health insurance were more likely to have received five of six 
recommended preventive services than persons without insurance.
However,
 regardless of insurance status, receipt was below 50% for three 
services and ranged from 17.9% for zoster vaccination to 62.0% for 
tetanus vaccination. 
    
What are the implications for public health practice?
    
Increased insurance coverage might lead to a 
substantial increase in receipt of preventive care and improvements in 
population health. 
However, low rates of service receipt even among 
those with insurance suggest that additional efforts beyond insurance 
coverage expansion might be needed to increase offering and use of 
services.
 
    
     
       
      
       | 
         
Clinical preventive service (age group) 
 | 
       
         
Recommendation 
 | 
       
         
Question to NHIS participants 
 | 
       
         
Key distinctions for this analysis of use of recommended services 
 | 
      
       | 
         
HIV test (age 18–65 years) 
 | 
       
         
HIV infection screening is 
recommended for persons aged 15–65 years. Screening is recommended for 
other age groups at increased risk. Recommended screening interval for 
the general population is not specified.* 
 | 
       
         
To adults aged ≥18 years: "Except for tests you may have had as part of blood donations, have you ever been tested for HIV?"† 
 | 
       
         
NHIS asks this question to those aged ≥18 years. Those aged 15–17 years are not included in the analysis. 
 | 
      
       | 
         
Smoking cessation discussion (age ≥18 years) 
 | 
       
         
Tobacco cessation interventions 
are recommended for those who use tobacco products. A recommended 
screening interval for the general population is not specified.* 
 | 
       
         
To adults aged ≥18 years who 
currently smoke cigarettes every day or some days: "During the past 12 
months, has a doctor or other health professional talked to you about 
your smoking?" 
 | 
       
         
Adults who use tobacco only in forms other than cigarettes are not included in the analysis. 
 | 
      
       | 
         
Influenza vaccination (age ≥18 years) 
 | 
       
         
Annual vaccination against influenza is recommended for all persons aged ≥6 months.§ 
 | 
       
         
To adults aged ≥18 years: "During
 the past 12 months, have you had a flu shot?" and "During the past 12 
months, have you had a flu vaccine sprayed in your nose by a doctor or 
other health professional?" A"yes" response to either question is coded 
as vaccination received. 
 | 
       
         
This analysis focuses on adults aged ≥18 years. 
 | 
      
       | 
         
Pneumococcal vaccination (age ≥65 years) 
 | 
       
         
Pneumococcal vaccination is 
recommended for all persons aged ≥65 years and for persons with certain 
other risk factors  aged <65 years.§ 
 | 
       
         
"Have you ever had a pneumonia shot?"† 
 | 
       
         
This analysis focuses on those aged ≥65 years. 
 | 
      
       | 
         
Tetanus vaccination (age ≥19 years) 
 | 
       
         
Vaccination with Td booster (or 1-time dose of Tdap) for all adults aged ≥19 years.§ 
 | 
       
         
To adults aged ≥18 years: "Have you received a tetanus shot in the past 10 years?" 
 | 
       
         
This analysis focuses on those aged ≥19 years for consistency with the recommendation for adults. 
 | 
      
       | 
         
Zoster (shingles) vaccination (age ≥60 years) 
 | 
       
         
Zoster vaccination is recommended for adults aged ≥60 years.§ 
 | 
       
         
To adults aged ≥50 years: "Have you ever had the zoster or shingles vaccine, also called Zostavax?"† 
 | 
       
         
This analysis focuses on those aged ≥60 years for consistency with the recommendation for adults. 
 | 
      
       
      
    
 
    
     
       
      
       | 
         
Clinical preventive service (age group) 
 | 
       
         
Insured receiving service 
 | 
       
         
Uninsured receiving service 
 | 
       
         
Prevalence  ratio,  insured/ uninsured* 
 | 
       
         
(95% CI) 
 | 
       
         
Total receiving service  
 | 
      
       | 
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
       
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
      
       | 
         
HIV test (ever) (age 18–65 years) 
 | 
       
         
40,823 
 | 
       
         
41.5 
 | 
       
         
(40.7–42.2) 
 | 
       
         
11,641 
 | 
       
         
43.1 
 | 
       
         
(41.9–44.3) 
 | 
       
         
1.0† 
 | 
       
         
(0.9–1.0) 
 | 
       
         
41.7 
 | 
       
         
(41.1–42.4) 
 | 
      
       | 
         
Smoking cessation discussion (within 12 mos) (age ≥18 years) 
 | 
       
         
8,935 
 | 
       
         
59.1 
 | 
       
         
(58.0–60.3) 
 | 
       
         
3,497 
 | 
       
         
32.7 
 | 
       
         
(31.1–34.4) 
 | 
       
         
1.8§ 
 | 
       
         
(1.7–1.9) 
 | 
       
         
52.0 
 | 
       
         
(51.0–53.0) 
 | 
      
       | 
         
Influenza vaccination (within 12 mos) (age ≥18 years) 
 | 
       
         
54,217 
 | 
       
         
44.2 
 | 
       
         
(43.6–44.7) 
 | 
       
         
11,888 
 | 
       
         
14.7 
 | 
       
         
(13.9–15.4) 
 | 
       
         
3.0§ 
 | 
       
         
(2.9–3.2) 
 | 
       
         
39.4 
 | 
       
         
(38.9–40.0) 
 | 
      
       | 
         
Pneumococcal vaccination (ever) (age ≥65 years) 
 | 
       
         
13,585 
 | 
       
         
61.7 
 | 
       
         
(60.6–62.7) 
 | 
       
         
113 
 | 
       
         
18.1 
 | 
       
         
(9.1–27.0) 
 | 
       
         
3.4§ 
 | 
       
         
(2.1–5.6) 
 | 
       
         
61.4 
 | 
       
         
(60.3–62.4) 
 | 
      
       | 
         
Tetanus vaccination (within 10 years) (age ≥19 years) 
 | 
       
         
51,872 
 | 
       
         
63.7 
 | 
       
         
(63.0–64.3) 
 | 
       
         
11,431 
 | 
       
         
53.7 
 | 
       
         
(52.6–54.8) 
 | 
       
         
1.2§ 
 | 
       
         
(1.2–1.2) 
 | 
       
         
62.0 
 | 
       
         
(61.5–62.6) 
 | 
      
       | 
         
Zoster vaccination (ever) (age ≥60 years) 
 | 
       
         
18,297 
 | 
       
         
18.4 
 | 
       
         
(17.6–19.2) 
 | 
       
         
868 
 | 
       
         
6.3 
 | 
       
         
(4.2–8.4) 
 | 
       
         
2.9§ 
 | 
       
         
(2.1–4.1) 
 | 
       
         
17.9 
 | 
       
         
(17.1–18.7) 
 | 
      
       
      
    
 
    
     
       
      
       | 
         
Clinical preventive service (age group) 
 | 
       
         
 Income >200% FPL receiving service 
 | 
       
         
 Income ≤200% FPL receiving service 
 | 
       
         
Prevalence  ratio,  higher income/ lower income* 
 | 
       
         
(95% CI) 
 | 
      
       | 
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
       
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
      
       | 
         
HIV test (ever) (age 18–65 years) 
 | 
       
         
31,948 
 | 
       
         
40.2 
 | 
       
         
(39.4–40.9) 
 | 
       
         
25,815 
 | 
       
         
44.6 
 | 
       
         
(43.5–45.7) 
 | 
       
         
0.9† 
 | 
       
         
(0.9–0.9) 
 | 
      
       | 
         
Smoking cessation discussion (within 12 mos) (age ≥18 years) 
 | 
       
         
6,068 
 | 
       
         
53.5 
 | 
       
         
(52.2–54.8) 
 | 
       
         
6,404 
 | 
       
         
50.4 
 | 
       
         
(48.9–51.9) 
 | 
       
         
1.1§ 
 | 
       
         
(1.0–1.1) 
 | 
      
       | 
         
Influenza vaccination (within 12 mos) (age ≥18 years) 
 | 
       
         
40,110 
 | 
       
         
42.8 
 | 
       
         
(42.2–43.4) 
 | 
       
         
26,201 
 | 
       
         
33.4 
 | 
       
         
(32.6–34.3) 
 | 
       
         
1.3† 
 | 
       
         
(1.3–1.3) 
 | 
      
       | 
         
Pneumococcal vaccination (ever) (age ≥65 years) 
 | 
       
         
8,268 
 | 
       
         
64.4 
 | 
       
         
(63.1–65.6) 
 | 
       
         
5,449 
 | 
       
         
56.2 
 | 
       
         
(54.5–57.9) 
 | 
       
         
1.1† 
 | 
       
         
(1.1–1.2) 
 | 
      
       | 
         
Tetanus vaccination (within 10 years) (age ≥19 years) 
 | 
       
         
38,893 
 | 
       
         
65.0 
 | 
       
         
(64.4–65.7) 
 | 
       
         
24,840 
 | 
       
         
56.6 
 | 
       
         
(55.7–57.5) 
 | 
       
         
1.1† 
 | 
       
         
(1.1–1.2) 
 | 
      
       | 
         
Zoster vaccination (ever) (age ≥60 years) 
 | 
       
         
12,025 
 | 
       
         
21.4 
 | 
       
         
(20.4–22.4) 
 | 
       
         
7,177 
 | 
       
         
11.3 
 | 
       
         
(10.3–12.3) 
 | 
       
         
1.9† 
 | 
       
         
(1.7–2.1) 
 | 
      
       
      
    
 
    
     
      
       
      
       | 
         
Clinical preventive service (age group) 
 | 
       
         
Private insurance receiving service 
 | 
       
         
Only public insurance receiving service 
 | 
       
         
Prevalence  ratio,  private/ public* 
 | 
       
         
(95% CI) 
 | 
      
       | 
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
       
         
No. 
 | 
       
         
% 
 | 
       
         
(95% CI) 
 | 
      
       | 
         
HIV test (ever) (age 18–65 years) 
 | 
       
         
31,605 
 | 
       
         
38.6 
 | 
       
         
(37.8–39.3) 
 | 
       
         
9,218 
 | 
       
         
53.0 
 | 
       
         
(51.6–54.3) 
 | 
       
         
0.7† 
 | 
       
         
(0.7–0.8) 
 | 
      
       | 
         
Smoking cessation discussion (within 12 mos) (age ≥18 years) 
 | 
       
         
5,399 
 | 
       
         
55.3 
 | 
       
         
(53.9–56.8) 
 | 
       
         
3,535 
 | 
       
         
65.8 
 | 
       
         
(64.0–67.5) 
 | 
       
         
0.8§ 
 | 
       
         
(0.8–0.9) 
 | 
      
       | 
         
Influenza vaccination (within 12 mos) (age ≥18 years) 
 | 
       
         
38,470 
 | 
       
         
42.4 
 | 
       
         
(41.8–43.1) 
 | 
       
         
15,738 
 | 
       
         
48.9 
 | 
       
         
(47.9–49.9) 
 | 
       
         
0.9§ 
 | 
       
         
(0.8–0.9) 
 | 
      
       | 
         
Pneumococcal vaccination (ever) (age ≥65 years) 
 | 
       
         
6,807 
 | 
       
         
66.1 
 | 
       
         
(64.8–67.4) 
 | 
       
         
6,769 
 | 
       
         
56.9 
 | 
       
         
(55.3–58.4) 
 | 
       
         
1.2§ 
 | 
       
         
(1.1–1.2) 
 | 
      
       | 
         
Tetanus vaccination (within 10 years) (age ≥19 years) 
 | 
       
         
36,917 
 | 
       
         
65.7 
 | 
       
         
(65.1–66.4) 
 | 
       
         
14,946 
 | 
       
         
57.9 
 | 
       
         
(56.9–58.9) 
 | 
       
         
1.1§ 
 | 
       
         
(1.1–1.2) 
 | 
      
       | 
         
Zoster vaccination (ever) (age ≥60 years) 
 | 
       
         
10,305 
 | 
       
         
20.4 
 | 
       
         
(19.4–21.4) 
 | 
       
         
7,984 
 | 
       
         
15.7 
 | 
       
         
(14.6–16.7) 
 | 
       
         
1.3§ 
 | 
       
         
(1.2–1.4) 
 |